GW 501516 is a synthetic peroxisome proliferator-activated receptor delta (PPARδ) agonist that was originally investigated for the treatment of metabolic disorders, including dyslipidemia and obesity,… Read more
GW 501516 is a synthetic peroxisome proliferator-activated receptor delta (PPARδ) agonist that was originally investigated for the treatment of metabolic disorders, including dyslipidemia and obesity, before clinical development was discontinued. This category offers a comprehensive collection of reference standards, including the parent drug, its primary metabolites, and key impurities, which are critical for laboratories performing rigorous analytical testing and quality control. By providing these essential compounds, the catalogue supports advanced research applications such as impurity profiling and method validation. Laboratories rely on these high-purity reference materials, including stable isotope labelled compounds, to ensure the accurate identification and quantification of degradation products and potential contaminants. These tools are indispensable for scientists developing robust analytical protocols to monitor complex metabolic modulators in various research and development environments.